OABI | OmniAbNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$5.15
+$0.06 (+1.18%)

OmniAb (OABI) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2023.

The 50 SMA has sat above the 200 on the daily since Jun 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $5.15 vs 50 $4.68 / 200 $2.73
Projection
No cross projected
Test
No active test
Last cross
Golden cross 1 Jun 2026 ยท projected 27 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $5.11 vs 50 $2.58 / 200 $3.52
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
above both $5.06 vs 50 $4.81 / 200 $3.60
Projection
No cross projected
Test
No active test
Last cross
Golden cross 22 May 2026 ยท projected 30 bars out

Cross history

16
crosses on record since 2023
8 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
1 Jun 2026Golden moderatedaily27 bars outNot tested
22 May 2026Golden4-hour30 bars outNot tested
1 Apr 2026Death moderatedaily9 bars outNot tested
25 Mar 2026Death4-hour29 bars outNot tested
19 Mar 2026Golden4-hour14 bars out5 bar cross test

About OABI

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2023
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.